Showcases Stock ranks

Bristol-Myers Squibb Company (BMY)
56.41 -0.07 (-0.12%) 11-20 16:01
Open: 56.16 Pre. Close: 56.48
High: 56.5 Low: 55.3
Volume: 57,421,829 Market Cap: 91908M
Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is Biopharmaceuticals.
Share on Facebook   Tweet this page
Price Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 56.671 - 56.988 56.988 - 57.279
Low: 54.458 - 54.875 54.875 - 55.257
Close: 55.981 - 56.59 56.59 - 57.149
Stock Technical Analysis
Target: Six months: 69.12
One year: 80.73
Support: Support1: 54.69
Support2: 51.91
Resistance: Resistance1: 59.18
Resistance2: 69.12
Pivot: 57.55
Moving Averages: MA(5): 57.56
MA(20): 57.04
MA(100): 49.80
MA(250): 49.18
MACD: MACD(12,26): 1.25
Signal(12,26,9): 1.58
%K %D: %K(14,3): 37.56
%D(3): 56.88
RSI: RSI(14): 55.29
52-Week: High: 59.18
Low: 42.48
Change(%): 6.4
Average Vol(K): 3-Month: 1232021
10-Days: 2011207
Price, MAs and Bollinger Bands
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.

BMY has closed above bottom band by 20.0%. Bollinger Bands are 18.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 1630.00
Shares Float (M) 1630.00
% Held by Insiders 0.11
% Held by Institutions 75.05
Shares Short (K) 149510
Shares Short Prior Month (K)
Stock Financials
EPS 3.460
Book Value (p.s.) 10.830
PEG Ratio 2.25
Profit Margin 23.39
Operating Margin 29.68
Return on Assets (ttm) 9.8
Return on Equity (ttm) 36.0
Qtrly Rev. Growth 5.6
Gross Profit (p.s.) 9.859
Sales Per Share
EBITDA (p.s.) 4.767
Qtrly Earnings Growth -28.80
Operating Cash Flow (M) 8460.00
Levered Free Cash Flow (M) 6080.00
Stock Valuation
P/E 16.36
P/E Growth Ratio
P/BV 5.23
P/S 3.82
P/CF 10.90
Dividend Yield 0.03
Dividends & Splits
Dividend 1.640
Dividend Pay Date 2019-11-01
Ex-Dividend Date 2019-10-03
Forward Dividend 1.640
Last Split Date
Last Split Ratio -1e+010

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator